There are an estimated 45 million blind people in the world of whom only 3% are children. 1 This dramatic diVerence in numbers of blind adults compared with children accounts in part for the relatively minor importance that has been attributed to the problem surrounding childhood blindness. Certainly, the well organised advocacy groups for the elderly in many developed countries are not matched by comparable ones for children. The result of this can be seen in the diVerence in resources made available for health services and research for adult blindness versus childhood blindness. One hopes that, now that the World Health Organization (WHO) and International Agency for Prevention of Blindness have developed a global initiative to eliminate avoidable blindness and have included childhood blindness as one of its five key areas, this will change. 2 In this issue of the BJO (p 1149) Kocur and co-workers report on the causes of severe visual impairment (visual acuity in the better eye less than 6/60) and blindness (visual acuity in the better eye less than 3/60) in the Czech Republic. This is an excellent study and the authors raise issues that go well beyond the borders of the Czech Republic. We wish to highlight only two of these issues.
First, and foremost, is the issue that the authors emphasise themselves-the continuing havoc resulting from retinopathy of prematurity (ROP). In this study ROP was the leading cause of blindness-41.9% had ROP. Although this figure appears to be staggering at first, similar studies in Bulgaria and Cuba have reported incident rates of 25.9% and 38/6% respectively. 3 The ever changing epidemiology of ROP is diYcult to summarise precisely. The simplistic view that ROP is becoming less of a problem in the more developed nations while being a major problem in emerging nations, who are just now beginning to establish intensive care neonatal units, is misleading. Isolated reports have suggested that the incidence of ROP is decreasing in developed nations. 4 5 A study in Denmark found a decrease in the incidence in ROP for infants with birth weights between 1251 and 1750 g but not for infants weighing less than 1251 g. 6 These smaller premature infants are more likely to suVer from ROP and the neurological sequelae of intraventricular haemorrhage and hypoxia. 7 The Light-ROP study showed no reduction in incidence of ROP. 8 At the present time in San Francisco, approximately 20% of children referred for preschool services to the Variety Club for Blind Babies Foundation have ROP. Increasingly, they are multiply handicapped with severe neurological and developmental problems. While it is true that improved neonatal care has resulted in an improved survival and quality of life for premature infants, ROP remains an important cause of childhood visual impairment in the developed world. Finally, although it is too little spoken of, the incidence of ROP in developed nations is significantly aVected by the guidelines established by neonatal units for resuscitating and supporting very ill tiny premature babies. This is an ethical dilemma in which open discussion and debate would be welcomed.
In the Third World where no neonatal units are available, ROP is, of course, not a problem. However, as emerging nations develop neonatal care nurseries ROP becomes a larger part of the picture of childhood blindness. Establishing guidelines for screening and treating ROP are essential in these countries. The study of Kocur and co-workers identified 96 children with ROP. Yet, only four of these children had been treated with cryotherapy. Surely, this suggests that many of these children were cared for in neonatal units that did not have adequate screening or treatment programmes for ROP. The emphasis of the authors on establishing such programmes is well placed. Certainly, in some parts of the world this is a staYng issue with too few available ophthalmologists trained to screen for ROP. Of course, even with a well established programme of screening for ROP our treatment options remain limited and not entirely eVective. 9 ROP remains a problem for all but the poorest nations without neonatal intensive care units.
Conspicuous by its insignificance in the study of Kocur and co-workers is cortical visual impairment. They found only four children in their study with this diagnosis. This is striking and deserves comment. In the developed world ocular causes of visual impairment and blindness in children have decreased in frequency during the 20th century. In contrast, various central nervous system disorders have become the most common causes of visual impairment in children in many countries. 10 11 The term cortical visual impairment has been used to describe these central nervous system disorders. The original definition of cortical visual impairment was loss of vision due to bilateral dysfunction of the optic radiations and/or visual cortex. Recently, however, it has regrettably been applied to a myriad of disorders including autism, learning disabilities, and attention deficit disorders. For the purpose of this discussion we shall use cortical visual impairment to describe children with visual loss due to optic radiation, striate cortex, and peristriate cortex damage. Causes of cortical visual impairment in children include, but are not limited to, perinatal hypoxia, near drowning episodes, hydrocephalus, trauma (including non-accidental), meningitis, and periventricular leucomalacia. Many of these children have damage to non-visual portions of the central nervous system and are therefore significantly handicapped in functions other than vision. Many have severe neurodevelopmental problems and for this reason often are excluded from residential schools for the blind. Since Kocur and co-workers performed their study in 10 primary schools for visually handicapped children this may account at least in part for why they found only four children with the diagnosis of cortical visual impairment.
The child with cortical visual impairment is challenging to his/her parents, physicians, and teachers. Standard techniques to evaluate visual function are often inadequate to describe precisely the extent and nature of visual impairment. Educational approaches for intervention designed for the child with ocular causes of visual impairment are often unsuccessful. Recently, educators have developed specific instructional intervention strategies for the child with cortical visual impairment; nevertheless, the potential for the child with cortical visual impairment to live an independent and productive life is often not good.
In San Francisco, the two leading causes of childhood blindness and visual impairment are ROP and cortical visual impairment. In some ways they both result from improved medical care and technology which has allowed very premature and/or severely brain damaged children to survive. It is not altogether precise to refer to them as iatrogenic disorders but there are complex diYcult ethical issues raised by these disorders which should remind us that advances in medical technologies are frequently accompanied by significant adverse eVects. If our goal is to eliminate preventable causes of blindness by 2020, ROP and cortical visual impairment must be involved in a major portion of the eVort on behalf of visually impaired children in the developed world. 
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CORRECTION
We are sorry that the paper "Outcome for staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis" 1 was accompanied by an editorial 2 based on outdated figures. Regrettably, we inadvertantly sent Dr Salmon the old version on which to base his article. Had he been sent the final version, he may have drawn more positive conclusions, as the results had improved over time. Unfortunately many readers may look at the editorial only, trusting that it provides an accurate summary, rather than the paper itself. Those who did take the trouble to read both articles side by side may have been confused by the apparent discrepancies.
We would like to take this opportunity to set the record straight, by providing updated versions of figures 1 and 2 from the paper. 1 These illustrate the continued improvement in survival rates following staged palliative reconstructive surgery for this previously fatal condition. The updated figures show that stage I survival has increased from 52% to 59%, and overall survival from 48% to 55%. For antenatally diagnosed babies, survival has risen from 49% to 55% (39/71), or from 44% to 50% (39/78) taken from an "intention to treat" basis.
The management of HLHS remains a challenge, but we are encouraged that short to medium term results continue to improve over time. Although the highest mortality still occurs at stage I, the prospects for a baby entering the Norwood programme in 2001 are considerably better than those from even 5 years ago; stage I survival has risen from 54% (7/13) in 1996 to 87% (13/15) in 2001 (p=0.05). The authors conclude that it is crucial that parents are given accurate, up-todate figures when they are counselled about the outcome of this condition. 3 
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